OTCPicks.com

BioNeutral Group

img

img

BioNeutral Group
(OTCBB: BONU)

img

"Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene Eliminates Aspergillus Niger (Black Mold) Spores "

img

Financial Snapshot:

Business:
Life Science Technology
Exchange:
OTCBB
Symbol:
BONU
Current Price (07/07/09):
$0.54

img

BioNeutral Group (OTCBB: BONU)

Detailed Quote: http://www.otcpicks.com/quotes/BONU.php

img

Company Overviewimg

BioNeutral Group, Inc. is a publicly traded specialty life science company, organized in 2003 to commercialize a novel combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores.

The formulations are green and include natural and common ingredients which are found in baby products and in the foods we eat. We combine these widely-used compounds in unique ways to create enhanced results.

BioNeutral’s proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers.

BIONEUTRALIZERS, based on our proprietary Ygiene™ platform formulation, disinfect, decontaminate and sterilize. BioNeutral intends to market the broadest-based, fastest acting, most effective and safest anti­microbial known. This class of products has important applications for:

  • Healthcare Facilities
  • Consumers / Household use
  • Industrial Applications
  • Military / Homeland Security

It has the ability to eliminate Anthrax on contact.

CHEMONEUTRALIZERS, based on the Ogiene™ formula, irreversibly bind chemical contaminants and toxin molecules and render them harmless. Product applications include:

  • Industrial pollution
  • Environmental contaminants
  • Protection against chemical weapons of mass destruction.

It even eliminates lethal toxins like formaldehyde.

The hallmark of the BioNeutral approach is based on maximum value in providing the best in class products in our field of expertise and our ability to identify and address the areas of greatest need.

Investment Highlights

  • OgieneTM formulations that include products with and without fragrances have been upgraded and finalized.
  • Initial application work has been initiated for Ogiene™ products.Highly effective antimicrobial formulations that are reproducible and stable have been developed.
  • Extensive laboratory studies have demonstrated that Ygiene™ is a broad spectrum antimicrobial and will be preferred for many high level disinfectant and sterilant applications.
  • Patents have been applied for relating to the composition, application process and methods of use for Ogiene™ and Ygiene™ products.
  • Ygiene™ has been successfully manufactured by the firm’s contract manufacturer.
  • License discussions have been initiated for Ygiene™ with major international consumer products companies, a leading international product distributor and a leading military/homeland securing contractor.

Technology

BioNeutral has two different technology platforms which underpin the Ygiene™ and Ogiene™ formulations.

The formulation has several interesting characteristics/capabilities:

  • BioNeutral has developed a family of "green" formulations which are sporicidal, bactericidal and viracidal – at room temperature.
  • We have developed the chemical technology and understand how to manipulate the formulations to address requirements that can vary the "kill time" (from seconds to minutes) and the breadth of kill (class of organisms – up to the most difficult to eradicate - spores) depending upon the needs of the market.
  • The ingredients, when combined, have lower toxicity and far greater efficacy then anticipated. The formulations are stable, non corrosive, non flammable and water soluble.
  • The formulations can be applied as a liquid, wet wipe, spray, mist/fog or foam/froth and can be applied to air, surface and water.

YGIENEimg

Dr. Philip Tierno, Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center:

"There is nothing better. (Virtually nothing compares with it). There is nothing that works faster. (Kills in seconds). There is nothing that has a more complete kill. (Kills 100% of organisms).
There is nothing wider in spectrum. (Kills any and all microbes). And it is an environmentally green product. (It eventually breaks down into innocuous substances)."

These exceptional properties of Ygiene™ are a result of the manner in which the chemical components are assembled and the resulting chemistry exhibited by these formulations.

  • Ygiene™ is peroxy based and can deliver more active ingredient than any currently available antimicrobial. This is a result of our know how which allows the formulation components to act as a latent source or reservoir of active ingredients.
  • Ygiene™ has lasting power that far exceeds competitive products. In addition with a low initial active level, Ygiene™ is mild. For example, with a low initial level of actives Ygiene™ is not corrosive. In a very demanding iron corrosion test we have not found a commercial antimicrobial product which is as noncorrosive as Ygiene™.
  • Ygiene™ posses a unique balance of reactive chemistry and exceptional efficacy which far exceeds competitive antimicrobials (for details click here).

There are three categories of Ygiene formulations that are intended to serve a broad range of markets:

  • Military/first responders/hospital sterilant/specialty industrial This is kill on contact for anthrax and all micro organisms. Application instructions and protection against direct contact with skin and eyes is required.
  • Hospital/health care /mold/industrial applications include high level disinfection for hospitals and other health care facilities, eradication of mold and industrial cleaning in food preparation and other demanding environments (some application instructions and some protection against direct contact with skin and eyes is required). Will kill organisms in under 1 minute and will perform to a very high standard.
  • Consumer products/light industrial/health care – General areas of the hospital, nursing home, physician or dental office. Very mild yet sporacidal, bactericidal and viracidal. Can be used as a superior skin sanitizer.

In each category, Ygiene produces results superior to those formulations presently in the market.

OGIENE

BioNeutral's Ogiene formulations complex a broad range of dangerous and noxious chemicals and removes them from the air. Our Ogiene™ formulations interact with the functional organic or inorganic groups of the harmful gases.

Our Ogiene™ formulations can complex, convert to salts or irreversibly react with toxic/odorous gases and render them harmless. These formulations are also water based and can be applied to air, surfaces and water. These gasses include:

  • Formaldehyde (presently a considerable problem with temporary dwellings used by FEMA to house victims of natural disasters)
  • Hydrogen cyanide (produced when burning certain materials),
  • Ammonia
  • Carbon dioxide (byproducts of animal waster in confined quarters – eg pigs/poultry),
  • Sulfur dioxide/ nitrogen oxide (greenhouse gasses) and other dangerous chemicals.
  • We are in advanced testing utilizing air handling equipment with our technology to clean the air of dangerous chemicals.

BIONEUTRAL'S APPLICATION FOR ADDRESSING FORMALDEHYDE IN TEMPORARY AND PERMANENT HOUSING STRUCTURES:

While BioNeutral is actively developing products designed to address a variety of microbial and chemical issues, there is an urgent need for a solution to the serious problem of high levels of formaldehyde that has been detected in temporary and, more recently, permanent housing structures.

There are over 100,000 men, woman and children living in app 40,000 trailers in New Orleans and the Gulf states. Testing by the Centers for Disease Control has shown that the average amount of formaldehyde contained in these trailers exceeds safety levels with significant implications for public health. There is a broader market in excess of 1 million trailers and temporary housing throughout the United States used as schools, by the military and sold to the recreational market.

  • FEMA, state and local governmental departments are committed to moving the residents, at enormous cost, but have no place to move them to. There has not been any technology which has been shown to be effective in addressing this problem – until now.
  • Field testing has conclusively shown that the company’s ChemoNeutralizer is extremely effective in eliminating formaldehyde from the air. The formaldehyde is complexed and cannot be re-released into the environment or be modified into another dangerous substance.
  • The test results show that the poison is eliminated down to the lowest risk levels for long term exposure and are expected to meet anticipated new regulations which manufacturers are required to meet and have thus far failed to achieve. Follow-up measurements showed a return to pre-treatment levels.
  • Follow-up experiments with a passive static scavenging system has led to the development of a fan-based filtration system (using the Ogiene™ CE formulation) that is expected to continually maintain minimal risk levels of formaldehyde.

The ChemoNeutralizer formulation has been tested in trailers and the test results have been incorporated into a summary report and press release (see graph below). The company has been in touch with the CDC, FEMA, EPA, trailer manufacturers and the Sierra Club who were responsible for bringing the problem to the awareness of the public and to hold the government responsible for addressing this disgrace. Average formaldehyde levels, as shown by CDC testing are, at least 9-times greater than recommended long term exposure.

OTHER OGIENE APPLICATIONS - ADDRESSING FORMALDEHYDE IN APPAREL:

BioNeutral's Ogiene technology also has other applications: namely neutralizing harmful chemicals that are present in women's apparel due to some companies' manufacturing processes. Formaldehyde has been discovered in well known brands of expensive lingerie, and Ogiene applications will allow consumers you to clean with the essence of nature while neutralizing harmful chemicals found in apparel.

Many fabrics are treated with formaldehyde resins. Allergic or irritant reactions to clothing is more often a result of the rubber materials, formaldehyde finishing resins, chemical additives, dyes, glues and tanning agents used in processing the fabric or clothing or metallic fasteners. Elastic in clothing material such as brassieres and the waistband in underwear or pants can cause contact dermatitis where there is contact of the clothing item with the skin. The areas involved are subjected to friction and perspiration, which contributes to the uncomfortable skin lesions.

Textile formaldehyde resins are used in materials such as cotton or cotton/polyester blend fabrics to make the fabric wrinkle-resistant. There are nine formaldehyde resins in current use in the United States and MOST do not release a significant amount of formaldehyde as older formulations in the past.

Applications

HEALTHCARE FACILITIES APPLICATIONS

Hospital/health care /mold/industrial applications include high level disinfection for hospitals and other health care facilities, eradication of mold and industrial cleaning in food preparation and other demanding environments (some application instructions and some protection against direct contact with skin and eyes is required). Will kill organisms in under 1 minute and will perform to a very high standard.

CONSUMER / HOUSEHOLD APPLICATIONS

Consumer products/light industrial/health care – General areas of the hospital, nursing home, physician or dental office. Very mild yet sporacidal, bactericidal and viracidal. Can be used as a superior skin sanitizer. In each category, Ygiene produces results superior to those formulations presently in the market.

MILITARY / INDUSTRIAL GRADE APPLICATIONS

Military/first responders/hospital sterilant/specialty industrial This is kill on contact for anthrax and all micro organisms. Application instructions and protection against direct contact with skin and eyes is required.

img

Recent BONU News:

July 7 - Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores

BioNeutral Group, Inc. ('BioNeutral') (OTC Bulletin Board: BONU), a chemical technology-based Life Science company announced today that independent laboratory testing performed by ATS Labs shows that Aspergillus Niger mold spores are completely eliminated by the Company's Ygiene(TM) Hospital Grade antimicrobial in record time.

ATS Labs, using the EPA required Fungicidal Use Dilution test, showed that approximately 2.5 million Aspergillus Niger spores were totally eliminated within two (2) minutes. Aspergillus Niger is a type of black mold spore which is a prolific human heath threatening problem. The spore form of this black mold is particularly difficult to eliminate and total eradication is required in order to alleviate associated health threatening issues.

BioNeutral's Chief Science Officer, Dr. Andy Kielbania, PhD. stated, 'These results are particularly important because they both validate our internal lab testing protocols and also confirm the speed, efficacy and power of our Ygiene(TM) antimicrobials. The sporicidal efficacy against Aspergillus Niger (Black Mold) is a key accomplishment for our company.' He continued, 'These independent lab test results represent a significant achievement. Based upon these results we believe our hospital grade Ygiene(TM) will easily eliminate any health threatening bacteria including very dangerous and difficult to kill antibiotic resistant forms including, Methicillan Resistant Staphylococcus Aureus often referred to as 'MRSA', drug resistant Pseudomonas Aeruginosa and the very difficult to eradicate pan resistant Klebsiella Pneumoniae. Obviously the new strain of H1N1 virus (Swine Flu) will not present any problem for our formula to achieve a total Kill in record time.'

In an article in Environmental Business International, Inc., The Chelsea Group, an Indoor Air Quality (IAQ) consulting and market research firm, estimates the IAQ market caused by toxic mold to be $2 to $3 billion annually and Anthony Worthan, President and COO of Air Quality Sciences, an IAQ consulting firm in Atlanta, estimates the IAQ market to be growing at an annual rate of 25%.

'These positive independent laboratory results validate that our Hospital Grade formula is now well on its way to becoming the next generation technology in EPA approved disinfectants and sterilants for health care facilities around the world,' stated Stephen J. Browand, President and CEO of BioNeutral Group, Inc. 'I am confident that our rigorous independent testing program will continue to validate our advanced technology performance with a 100% Total Kill at record speed, while also remaining friendly to people and the environment.'


BioNeutral Group

NJ Institute of Technology / EDC
211 Warren St. Newark, NJ 07103
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
http://www.bioneutralgroup.com/

 

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: OTCPicks.com has been compensated two thousand five hundred dollars by a third party (Blue Wave Advisors) for BONU advertising and promotional services.

 

Sign Up Today - It's FREE!

Clicky Web Analytics